292 related articles for article (PubMed ID: 28333133)
1. Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases.
Álvarez M; Sebastián-Martín A; García-Marquina G; Menéndez-Arias L
Sci Rep; 2017 Mar; 7():44834. PubMed ID: 28333133
[TBL] [Abstract][Full Text] [Related]
2. Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine.
Feng JY; Myrick FT; Margot NA; Mulamba GB; Rimsky L; Borroto-Esoda K; Selmi B; Canard B
Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):89-107. PubMed ID: 16440988
[TBL] [Abstract][Full Text] [Related]
3. A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus.
Chunduri H; Rimland D; Nurpeisov V; Crumpacker CS; Sharma PL
Virol J; 2011 Jan; 8():33. PubMed ID: 21255423
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.
White KL; Margot NA; Wrin T; Petropoulos CJ; Miller MD; Naeger LK
Antimicrob Agents Chemother; 2002 Nov; 46(11):3437-46. PubMed ID: 12384348
[TBL] [Abstract][Full Text] [Related]
5. Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance.
Xu HT; Martinez-Cajas JL; Ntemgwa ML; Coutsinos D; Frankel FA; Brenner BG; Wainberg MA
Retrovirology; 2009 Feb; 6():14. PubMed ID: 19210791
[TBL] [Abstract][Full Text] [Related]
6. The balance between NRTI discrimination and excision drives the susceptibility of HIV-1 RT mutants K65R, M184V and K65r+M184V.
Ly JK; Margot NA; MacArthur HL; Hung M; Miller MD; White KL
Antivir Chem Chemother; 2007; 18(6):307-16. PubMed ID: 18320935
[TBL] [Abstract][Full Text] [Related]
7. Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
Álvarez M; Nevot M; Mendieta J; Martínez MA; Menéndez-Arias L
J Biol Chem; 2018 Feb; 293(7):2247-2259. PubMed ID: 29275329
[TBL] [Abstract][Full Text] [Related]
8. Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.
Deuzing IP; Charpentier C; Wright DW; Matheron S; Paton J; Frentz D; van de Vijver DA; Coveney PV; Descamps D; ; Boucher CA; Beerens N
J Virol; 2015 Jan; 89(1):833-43. PubMed ID: 25355888
[TBL] [Abstract][Full Text] [Related]
9. Reduced viral fitness and lack of cross-class resistance with integrase strand transfer inhibitor and nucleoside reverse transcriptase inhibitor resistance mutations.
Andreatta KN; Goodman DD; Miller MD; White KL
Antimicrob Agents Chemother; 2015; 59(6):3441-9. PubMed ID: 25824231
[TBL] [Abstract][Full Text] [Related]
10. Endogenous reverse transcriptase assays reveal synergy between combinations of the M184V and other drug resistance-conferring mutations in interactions with nucleoside analog triphosphates.
Quan Y; Gu Z; Li X; Liang C; Parniak MA; Wainberg MA
J Mol Biol; 1998 Mar; 277(2):237-47. PubMed ID: 9514745
[TBL] [Abstract][Full Text] [Related]
11. High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen.
Descamps D; Damond F; Matheron S; Collin G; Campa P; Delarue S; Pueyo S; Chêne G; Brun-Vézinet F;
J Med Virol; 2004 Oct; 74(2):197-201. PubMed ID: 15332266
[TBL] [Abstract][Full Text] [Related]
12. Increased misincorporation fidelity observed for nucleoside analog resistance mutations M184V and E89G in human immunodeficiency virus type 1 reverse transcriptase does not correlate with the overall error rate measured in vitro.
Drosopoulos WC; Prasad VR
J Virol; 1998 May; 72(5):4224-30. PubMed ID: 9557711
[TBL] [Abstract][Full Text] [Related]
13. Differential influence of nucleoside analog-resistance mutations K65R and L74V on the overall mutation rate and error specificity of human immunodeficiency virus type 1 reverse transcriptase.
Shah FS; Curr KA; Hamburgh ME; Parniak M; Mitsuya H; Arnez JG; Prasad VR
J Biol Chem; 2000 Sep; 275(35):27037-44. PubMed ID: 10833521
[TBL] [Abstract][Full Text] [Related]
14. Thermostable HIV-1 group O reverse transcriptase variants with the same fidelity as murine leukaemia virus reverse transcriptase.
Barrioluengo V; Alvarez M; Barbieri D; Menéndez-Arias L
Biochem J; 2011 Jun; 436(3):599-607. PubMed ID: 21446917
[TBL] [Abstract][Full Text] [Related]
15. Drug Susceptibility and Viral Fitness of HIV-1 with Integrase Strand Transfer Inhibitor Resistance Substitution Q148R or N155H in Combination with Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Resistance Substitutions.
Andreatta KN; Miller MD; White KL
Antimicrob Agents Chemother; 2016 Feb; 60(2):757-65. PubMed ID: 26574015
[TBL] [Abstract][Full Text] [Related]
16. The impact of multidideoxynucleoside resistance-conferring mutations in human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and error specificity.
Rezende LF; Curr K; Ueno T; Mitsuya H; Prasad VR
J Virol; 1998 Apr; 72(4):2890-5. PubMed ID: 9525609
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
Chen R; Yokoyama M; Sato H; Reilly C; Mansky LM
J Virol; 2005 Sep; 79(18):12045-57. PubMed ID: 16140780
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 reverse transcriptase (RT) genotypic patterns and treatment characteristics associated with the K65R RT mutation.
Boucher S; Recordon-Pinson P; Ragnaud JM; Dupon M; Fleury H; Masquelier B
HIV Med; 2006 Jul; 7(5):294-8. PubMed ID: 16945074
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance.
Smith RA; Anderson DJ; Pyrak CL; Preston BD; Gottlieb GS
J Infect Dis; 2009 May; 199(9):1323-6. PubMed ID: 19358668
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial database.
McColl DJ; Chappey C; Parkin NT; Miller MD
Antivir Ther; 2008; 13(2):189-97. PubMed ID: 18505170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
